Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome

British Journal of Haematology

Volumn 166, Issue 5, 2014, Pages 729-738

  Arons, Evgeny ^a   Adams, Sharon ^b   Venzon, David J ^a   Pastan, Ira ^a   Kreitman, Robert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

03; ADAMTS13; HLA DQB1; Moxetumomab pasudotox; Recombinant immunotoxin; Thrombotic microangiopathy

Indexed keywords

BACTERIAL TOXIN; EXOTOXIN; HLA DRB1 ANTIGEN; HLA-DRB1*11 ANTIGEN; MOXETUMOMAB PASUDOTOX;

ADULT; AGED; ALLELE; BIOSYNTHESIS; DONOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HEMOLYTIC-UREMIC SYNDROME; HUMAN; IMMUNOLOGY; LEUKEMIA, HAIRY CELL; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BACTERIAL TOXINS; EXOTOXINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEMOLYTIC-UREMIC SYNDROME; HLA-DRB1 CHAINS; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; RISK FACTORS; THROMBOTIC MICROANGIOPATHIES; TISSUE DONORS; YOUNG ADULT;

EID: 84906046015     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12956     Document Type: Article

References (51)

1. Annino, L., Ferrari, A., Laurenti, L., Perrone, M.P., Romani, C., Pacchiarotti, A., Girelli, G. & Mandelli, F. (1994) HLA typing in hairy cell leukemia. Leukaemia & Lymphoma, 14, 63-65.
2. Aristeguieta, C. & de Perio, M.A. (2011) Three cases of hairy cell leukemia in coal miners. Leukaemia & Lymphoma, 52, 2391-2392.
3. Arons, E., Sunshine, J., Suntum, T. & Kreitman, R.J. (2006) Somatic hypermutation and VH gene usage in hairy cell leukemia. British Journal of Haematology, 133, 504-512.
4. Arons, E., Suntum, T., Sunshine, J., Stetler-Stevenson, M. & Kreitman, R.J. (2007) Immunoglobulin light chain repertoire in hairy cell leukemia. Leukemia Research, 31, 1239-1244.
5. Arons, E., Suntum, T., Stetler-Stevenson, M. & Kreitman, R.J. (2009) VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood, 114, 4687-4695.
6. Arons, E., Roth, L., Sapolsky, J., Suntum, T., Stetler-Stevenson, M. & Kreitman, R.J. (2011) Evidence of canonical somatic hypermutation in hairy cell leukemia. Blood, 117, 4844-4851.
7. Bouroncle, B.A., Wiseman, B.K. & Doan, C.A. (1958) Leukemic reticuloendotheliosis. Blood, 13, 609-630.
8. Casado, L.F., Mouleon, P., Villarrubia, B., Toledo, M.C. & Martinez-Frejo, M.C. (1998) Familial hairy cell leukemia: a HLA-linked disease or farmers-linked disease? Haematologica, 83, 751-752.
9. Chanock, S.J., Foster, C.B., Miller, F.W. & O'Hanlon, T.P. (2004) HLA-A, -B, -Cw, -DQA1 and -DRB1 alleles in a Caucasian population from Bethesda, USA. Human Immunology, 65, 1211-1223.
10. Cho, J.H. & Gregersen, P.K. (2011) Genomics and the multifactorial nature of human autoimmune disease. New England Journal of Medicine, 365, 1612-1623.
11. Climent, C., Nazario, C.M., Umpierre, S., Quintero, M. & Gorbea, S. (2007) Major histocompatibility complex class II polymorphisms and risk of cervical cancer in Puerto Rican women. Puerto Rico Health Sciences Journal, 26, 97-101.
12. Colovic, M.D., Jankovic, G.M. & Wiernik, P.H. (2001) Hairy cell leukemia in first cousins and review of the literature. European Journal of Haematology, 67, 185-188.
13. Coppo, P., Bengoufa, D., Veyradier, A., Wolf, M., Bussel, A., Millot, G.A., Malot, S., Heshmati, F., Mira, J.P., Boulanger, E., Galicier, L., Durey-Dragon, M.A., Fremeaux-Bacchi, V., Ramakers, M., Pruna, A., Bordessoule, D., Gouilleux, V., Scrobohaci, M.L., Vernant, J.P., Moreau, D., Azoulay, E., Schlemmer, B., Guillevin, L., Lassoued, K., Reseau d'Etude des Microangiopathies Thrombotiques de, l.A. (2004) Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore), 83, 233-244.
14. Coppo, P., Busson, M., Veyradier, A., Wynckel, A., Poullin, P., Azoulay, E., Galicier, L. & Loiseau, P. (2010) HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians. Journal of Thrombosis and Haemostasis, 8, 856-859.
15. Davis, R.E., Ngo, V.N., Lenz, G., Tolar, P., Young, R.M., Romesser, P.B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., Xu, W., Shaffer, A.L., Wright, G., Xiao, W., Powell, J., Jiang, J.K., Thomas, C.J., Rosenwald, A., Ott, G., Muller-Hermelink, H.K., Gascoyne, R.D., Connors, J.M., Johnson, N.A., Rimsza, L.M., Campo, E., Jaffe, E.S., Wilson, W.H., Delabie, J., Smeland, E.B., Fisher, R.I., Braziel, R.M., Tubbs, R.R., Cook, J.R., Weisenburger, D.D., Chan, W.C., Pierce, S.K. & Staudt, L.M. (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature, 463, 88-92.
16. Dores, G.M., Matsuno, R.K., Weisenburger, D.D., Rosenberg, P.S. & Anderson, W.F. (2008) Hairy cell leukaemia: a heterogeneous disease? British Journal of Haematology, 142, 45-51.
17. Feng, S., Eyler, S.J., Zhang, Y., Maga, T., Nester, C.M., Kroll, M.H., Smith, R.J. & Afshar-Kharghan, V. (2013) Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood, 122, 1487-1493.
18. Forconi, F., Sozzi, E., Rossi, D., Sahota, S.S., Amato, T., Raspadori, D., Trentin, L., Leoncini, L., Gaidano, G. & Lauria, F. (2008) Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia. Haematologica, 93, 697-705.
19. Forconi, F., Potter, K.N., Wheatley, I., Darzentas, N., Sozzi, E., Stamatopoulos, K., Mockridge, C.I., Packham, G. & Stevenson, F.K. (2010) The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood, 115, 71-77.
20. Freidel, A.C., Gebuhrer, L., Betuel, H., Farre, A., Labonne, M.P. & Lambert, J. (1991) HLA-DRw11, DQw7 has four cellular subtypes revealed by homozygous typing cells and undetected by restriction fragment length polymorphism. Human Immunology, 30, 183-189.
21. Gonzalez-Galarza, F.F., Christmas, S., Middleton, D. & Jones, A.R. (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Research, 39, D913-D919.
22. Hochberg, Y. & Benjamini, Y. (1990) More powerful procedures for multiple significance testing. Statistics in Medicine, 9, 811-818.
23. Hockley, S.L., Giannouli, S., Morilla, A., Wotherspoon, A., Morgan, G.J., Matutes, E. & Gonzalez, D. (2010) Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. British Journal of Haematology, 148, 666-669.
24. Jasper, G.A., Arun, I., Venzon, D., Kreitman, R.J., Wayne, A.S., Yuan, C.M., Marti, G.E. & Stetler-Stevenson, M. (2011) Variables affecting the quantitation of CD22 in neoplastic B cells. Cytometry. Part B, Clinical Cytometry, 80, 83-90.
25. Klaus, C., Plaimauer, B., Studt, J.D., Dorner, F., Lammle, B., Mannucci, P.M. & Scheiflinger, F. (2004) Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. Blood, 103, 4514-4519.
26. Kreitman, R.J., Wilson, W.H., Bergeron, K., Raggio, M., Stetler-Stevenson, M., FitzGerald, D.J. & Pastan, I. (2001) Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. New England Journal of Medicine, 345, 241-247.
27. Kreitman, R.J., Squires, D.R., Stetler-Stevenson, M., Noel, P., Fitzgerald, D.J., Wilson, W.H. & Pastan, I. (2005) Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies. Journal of Clinical Oncology, 23, 6719-6729.
28. Kreitman, R.J., Stetler-Stevenson, M., Margulies, I., Noel, P., FitzGerald, D.J.P., Wilson, W.H. & Pastan, I. (2009) Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. Journal of Clinical Oncology, 27, 2983-2990.
29. Kreitman, R.J., Tallman, M.S., Robak, T., Coutre, S., Wilson, W.H., Stetler-Stevenson, M., FitzGerald, D.J., Lechleider, R. & Pastan, I. (2012) Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia. Journal of Clinical Oncology, 30, 1822-1828.
30. Machulla, H.K., Muller, L.P., Schaaf, A., Kujat, G., Schonermarck, U. & Langner, J. (2001) Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients. International Journal of Cancer, 92, 203-207.
31. Martin-Jimenez, P., Garcia-Sanz, R., Gonzalez, D., Balanzategui, A., Perez, J.J., Caballero, M.D., Sarasquete, M.E., Galende, J., Orfao, A., Lopez-Berges, M.C., San Miguel, J.F. & Gonzalez, M. (2007) Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia. Clinical Lymphoma & Myeloma, 7, 573-579.
32. Matutes, E. (2006) Immunophenotyping and differential diagnosis of hairy cell leukemia. Hematology/oncology Clinics of North America, 20, 1051-1063.
33. Nieva, J. & Saven, A. (2007) Understanding hairy cell leukemia genetics. Leukaemia & Lymphoma, 48, 653-654.
34. Paydas, S. (2009) Hairy cell leukemia and bladder cancer in a patient: relation with dye exposure and review of the literaure. Advances in Hematology, 2009, 812960.
35. Pollack, M.S., Safai, B., Myskowski, P.L., Gold, J.W., Pandey, J. & Dupont, B. (1983) Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma. Tissue Antigens, 21, 1-8.
36. Reveille, J.D. (2005) Genetic studies in the rheumatic diseases: present status and implications for the future. Journal of Rheumatology. Supplement, 72, 10-13.
37. Robinson, J., Halliwell, J.A., McWilliam, H., Lopez, R., Parham, P. & Marsh, S.G. (2013) The IMGT/HLA database. Nucleic Acids Research, 41, D1222-D1227.
38. Rumi, E., Passamonti, F., Zibellini, S., Martinetti, M., Arcaini, L., Elena, C., Cazzola, M. & Lazzarino, M. (2007) HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia. Leukaemia & Lymphoma, 48, 805-807.
39. Salvatore, G., Beers, R., Margulies, I., Kreitman, R.J. & Pastan, I. (2002) Improved Cytotoxic activity towards cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display. Clinical Cancer Research, 8, 995-1002.
40. Scully, M., Brown, J., Patel, R., McDonald, V., Brown, C.J. & Machin, S. (2010) Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link. Journal of Thrombosis and Haemostasis, 8, 257-262.
41. Theodorou, I., Abel, L., Mauro, F., Duprey, B., Magnac, C., Payelle-Brogard, B., Davi, F. & Dighiero, G. (2002) High occurence of DRB1 11 in chronic lymphocytic leukaemia families. British Journal of Haematology, 119, 713-715.
42. Thorselius, M., Walsh, S.H., Thunberg, U., Hagberg, H., Sundstrom, C. & Rosenquist, R. (2005) Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia. Leukemia Research, 29, 153-158.
43. Tiacci, E., Trifonov, V., Schiavoni, G., Holmes, A., Kern, W., Martelli, M.P., Pucciarini, A., Bigerna, B., Pacini, R., Wells, V.A., Sportoletti, P., Pettirossi, V., Mannucci, R., Elliott, O., Liso, A., Ambrosetti, A., Pulsoni, A., Forconi, F., Trentin, L., Semenzato, G., Inghirami, G., Capponi, M., Di Raimondo, F., Patti, C., Arcaini, L., Musto, P., Pileri, S., Haferlach, C., Schnittger, S., Pizzolo, G., Foa, R., Farinelli, L., Haferlach, T., Pasqualucci, L., Rabadan, R. & Falini, B. (2011) BRAF mutations in hairy-cell leukemia. New England Journal of Medicine, 364, 2305-2315.
44. Tillmann, H.L. (2001) Hepatitis C virus infection. New England Journal of Medicine, 345, 1426; author reply 1427-1428.
45. Tobin, G., Thunberg, U., Karlsson, K., Murray, F., Laurell, A., Willander, K., Enblad, G., Merup, M., Vilpo, J., Juliusson, G., Sundstrom, C., Soderberg, O., Roos, G. & Rosenquist, R. (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood, 104, 2879-2885.
46. Venkataraman, G., Aguhar, C., Kreitman, R.J., Yuan, C.M. & Stetler-Stevenson, M. (2011) Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders. American Journal of Clinical Pathology, 136, 625-630.
47. Villemagne, B., Bay, J.O., Tournilhac, O., Chaleteix, C. & Travade, P. (2005) Two new cases of familial hairy cell leukemia associated with HLA haplotypes A2, B7, Bw4, Bw6. Leukaemia & Lymphoma, 46, 243-245.
48. Wang, S.S., Abdou, A.M., Morton, L.M., Thomas, R., Cerhan, J.R., Gao, X., Cozen, W., Rothman, N., Davis, S., Severson, R.K., Bernstein, L., Hartge, P. & Carrington, M. (2010) Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood, 115, 4820-4823.
49. Winchester, R., Toguchi, T., Szer, I., Burmester, G., Lo Galbo, P., Cuttner, J., Capra, J.D. & Nunez-Roldan, A. (1983) Association of susceptibility to certain hematopoietic malignancies with the presence of Ia allodeterminants distinct from the DR series; utility of monoclonal antibody reagents. Immunological Reviews, 70, 155-166.
50. Xi, L., Arons, E., Navarro, W., Calvo, K.R., Stetler-Stevenson, M., Raffeld, M. & Kreitman, R.J. (2012) Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood, 119, 3330-3332.
51. Yenigun, A. & Durupinar, B. (2002) Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection. Journal of Virology, 76, 1787-1789.